| Description | C16 Lactosylceramide is an endogenous bioactive sphingolipid. It forms membrane microdomains with Lyn kinase and the αi subunits of inhibitory G protein-coupled receptors (GPCRs), suggesting a role in cell signaling. Plasma levels of C16 lactosylceramide are elevated in insulin-resistant cattle. C16 Lactosylceramide is also upregulated in a mouse model of Niemann-Pick type C1 disease, a neurodegenerative cholesterol-sphingolipid lysosomal storage disorder. |
| molecular weight | 862.18 |
| Molecular formula | C46H87NO13 |
| CAS | 4201-62-1 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| Solubility | Chloroform:Methanol:H2O (2:1:0.1): Soluble |
C16 Lactosylceramide (d18:1/16:0)
CAS No.: 4201-62-1
C16 Lactosylceramide is an endogenous bioactive sphingolipid. It forms membrane microdomains with Lyn kinase and the αi
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.